Yohji Itoh
Oncology R&D, AstraZeneca
Osaka, Japan
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2-neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: April 18, 2023
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan.
Journal: Vaccine
Published: November 01, 2022
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 28, 2021
Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: May 04, 2021
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study).
Journal: Therapeutic advances in medical oncology
Published: July 03, 2019
The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China.
Journal: Therapeutic advances in respiratory disease
Published: June 27, 2019
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: November 04, 2018
The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies.
Journal: Influenza and other respiratory viruses
Published: February 27, 2018
Real-life effectiveness of budesonide/formoterol therapy in asthma: A subanalysis of the SMARTASIA study.
Journal: Allergy and asthma proceedings
Published: February 03, 2016
Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: May 22, 2015
Catastrophic health expenditure on acute coronary events in Asia: a prospective study.
Journal: Bulletin of the World Health Organization
Published: May 15, 2015
Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).
Journal: Clinical cardiology
Published: March 16, 2015
Last Updated: 09/26/2026